ArticleFrontiers in immunology2026
A predictive model based on maternal immune-inflammatory markers for ARDS identification in mechanically ventilated late-preterm and term neonates.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To develop and internally evaluate a model that uses maternal blood markers obtained before delivery to differentiate neonatal acute respiratory distress syndrome (ARDS) from other causes of respiratory distress in late-preterm and term neonates requiring mechanical ventilation. Methods: This retrospective study enrolled 227 mother-infant pairs from two tertiary hospitals between June 2024 and January 2026. Neonates born at 34-40 weeks' gestation with ventilation-dependent respiratory distress were divided into a training cohort and an internal test cohort. Predictors were screened using elastic-net regression with 1,000 bootstrap resamples. Four feature sets and six algorithms were then compared by 20 repeats of stratified five-fold cross-validation, and a six-predictor random forest (RF) was ultimately selected. Discrimination, calibration and net benefit were assessed, with 500-resample bootstrap optimism correction and Shapley additive explanation (SHAP) interpretation. Results: Maternal systemic immune-inflammation index (SII) and related inflammatory ratios were higher, and antenatal infection was more frequent, in the ARDS group, whereas recorded antenatal corticosteroid (ACS) use was less frequent (P < 0.001). Six predictors were retained in the final model: SII, antenatal infection, maternal age, gestational hypothyroidism, gestational diabetes mellitus and ACS use. The principal internal performance estimate, the mean training-set cross-validated area under the curve (AUC) was 0.729 ± 0.080, the fixed-pipeline optimism-corrected AUC was 0.793 and the internal test-set AUC was 0.827 (95% CI, 0.712-0.923), with an average precision of 0.828 and a Brier score of 0.175. These three values are not interchangeable and are reported as one principal and two secondary estimates, and none represents fully independent performance. At the training-derived threshold of 0.424, sensitivity was 78.8% and specificity 77.8%. SHAP identified SII as the largest contributor, without implying a causal effect for any predictor. Logistic regression using the same six predictors reached a numerically higher internal test-set AUC (0.838 versus 0.827, ΔAUC = -0.011, P = 0.744) and a cross-validated AUC of 0.706 ± 0.082 versus 0.729 ± 0.080, the RF therefore conferred no discriminative advantage. Conclusions: In mechanical ventilation needed neonates born at 34-40 weeks' gestation with respiratory distress, the six-predictor RF showed moderate discrimination, whereas evidence of adequate calibration was limited. The model remains preliminary and requires external validation, recalibration and prospective clinical-impact evaluation before clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.